2019 Global Biopharmaceutical CDMO Development Summit Forum - Cell and Gene Therapy Conference Sharing

Against the backdrop of the trend of biopharmaceutical innovation in China, the demand for mature antibody drug CDMO has gradually given rise to new types of drug CDMO demand, such as CAR-T cell therapy, gene therapy, novel antibody therapy, microbial drugs, extracellular vesicle drugs, and so on. Many excellent enterprises have also emerged in these fields. There are still many problems to be solved in the industry.

On August 3-4, Yimaike will invite CDMO leading enterprises and related biopharmaceutical companies to hold the "First Global Biopharmaceutical CDMO Development Summit Forum" to jointly explore the technology sharing and development transformation of innovative drug CDMO.    

Date: August 3-4, 2019

Location: Four Points by Sheraton Suzhou Hotel

Host: Yimaike

Co organizers: Xingyao Research Institute, Fengke Interview, Letu Youjia Pharmaceutical
Conference scale: 700+
Participants: 60% of biopharmaceutical companies, 30% of CRO/CDMO companies, and 10% of investment institutions